INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • Form 4 transactions

    67,560 records
    Side
    allbuysell
    Score
    any≥ 30≥ 50≥ 70
    Sort
    Newest disclosedNewest executedInsider ScoreValue
    Include
    grants & admin
    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    5
    TK
    Truong KristinaChief Accounting Officer
    ENVXEnovix Corp
    Grant or award
    A—
    12.5K sh
    Aug 28, 2026Sep 1, 2026
    Page 420 of 1689
    ← PrevNext →
    traded Aug 28, 2026
    +4d
    SEC Form 4

    Evidence

    5
    BR
    Bottorff RebeccaDirector, Chief People Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    1,487 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    SB
    Sousa Mauad BrunoDirector
    AUGOAura Minerals Inc.
    Derivative conversion
    C$210K
    2,497 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    MD
    McClymont DonaldDirector, Chief Executive Officer
    INDIindie Semiconductor, Inc.
    Option exercise
    M—
    90.8K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    TK
    Truong KristinaChief Accounting Officer
    ENVXEnovix Corp
    Tax withholding
    F$22K
    6,626 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    SB
    Sousa Mauad BrunoDirector
    AUGOAura Minerals Inc.
    Derivative conversion
    C$85K
    1,000 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    BR
    Bottorff RebeccaDirector, Chief People Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    4,121 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    5
    RA
    Renner AlexandraChief Product Officer
    OKLOOklo Inc.
    Option exercise
    M—
    4,173 sh
    Aug 31, 2026Sep 1, 2026
    traded Aug 31, 2026
    +1dSEC Form 4

    Evidence

    4
    BR
    Britt Christopher RDirector, Chief Executive Officer
    CHYMChime Financial, Inc.
    Derivative conversion · 10b5-1 plan
    C—
    88.6K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    3
    WA
    Williams Jennifer A.SVP, Chief Accounting Officer
    TRUTransUnion
    Tax withholding · 10b5-1 plan
    F$38K
    446 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    3
    MB
    Mulligan BrendanGeneral Counsel and Secretary
    FIGFigma, Inc.
    Open-market sale · 10b5-1 plan
    SELL$3,089
    100 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    3
    CM
    Cieri MichaelChief Product Officer
    BILLBILL Holdings, Inc.
    Option exercise · 10b5-1 plan
    M—
    6,531 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    3
    DM
    Doyle MittieChief Medical Officer
    AVTXAvalo Therapeutics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$14K
    679 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    WM
    Wittmann MichaelChief Operating Officer
    INDIindie Semiconductor, Inc.
    Option exercise
    M—
    33.0K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    WM
    Wittmann MichaelChief Operating Officer
    INDIindie Semiconductor, Inc.
    Option exercise
    M—
    6,250 sh
    Aug 31, 2026Sep 1, 2026
    traded Aug 31, 2026
    +1dSEC Form 4

    Evidence

    2
    RK
    Ross KadeChief Information Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    446 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    AD
    Agarwal DeveshChief Operating Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    2,086 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    AD
    Agarwal DeveshChief Operating Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    3,927 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    KM
    Krupka Devin MController, PAO
    BANDBandwidth Inc.
    Option exercise
    M—
    2,775 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    SB
    Sousa Mauad BrunoDirector
    AUGOAura Minerals Inc.
    Derivative conversion
    C$33K
    1,168 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    WM
    Wittmann MichaelChief Operating Officer
    INDIindie Semiconductor, Inc.
    Grant or award
    A—
    33.0K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    RK
    Ross KadeChief Information Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    1,853 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    RK
    Ross KadeChief Information Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    446 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    2
    RK
    Ross KadeChief Information Officer
    BANDBandwidth Inc.
    Option exercise
    M—
    3,392 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    1
    HG
    Hansen GwennChief Scientific Officer
    NRIXNurix Therapeutics, Inc.
    Open-market sale · 10b5-1 plan
    SELL$37K
    1,452 sh
    Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    +0dSEC Form 4

    Evidence

    0
    DM
    Doyle MittieChief Medical Officer
    AVTXAvalo Therapeutics, Inc.
    Option exercise · 10b5-1 plan
    M—
    679 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    0
    BR
    Britt Christopher RDirector, Chief Executive Officer
    CHYMChime Financial, Inc.
    Derivative conversion · 10b5-1 plan
    C—
    88.6K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    0
    JR
    Jain RohiniChief Financial Officer
    BILLBILL Holdings, Inc.
    Option exercise · 10b5-1 plan
    M—
    50.3K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    0
    HT
    Hamilton Brian TDirector, President of CCBX
    CCBCOASTAL FINANCIAL CORP
    Tax withholding · 10b5-1 plan
    F$11K
    232 sh
    Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    +0dSEC Form 4

    Evidence

    0
    CM
    Cieri MichaelChief Product Officer
    BILLBILL Holdings, Inc.
    Option exercise · 10b5-1 plan
    M—
    12.9K sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    0
    HG
    Hansen GwennChief Scientific Officer
    NRIXNurix Therapeutics, Inc.
    Option exercise · 10b5-1 plan
    M—
    1,452 sh
    Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    +0dSEC Form 4

    Evidence

    0
    DM
    Doyle MittieChief Medical Officer
    AVTXAvalo Therapeutics, Inc.
    Option exercise · 10b5-1 plan
    M$5,459
    679 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC Form 4

    Evidence

    0
    HG
    Hansen GwennChief Scientific Officer
    NRIXNurix Therapeutics, Inc.
    Option exercise · 10b5-1 plan
    M$2,701
    1,452 sh
    Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    +0dSEC Form 4

    Evidence

    56
    SH
    Schuetz Arthur Josef HermannCFO Schmid Group N.V.
    SHMDSCHMID Group N.V.
    Open-market purchase
    BUY$49K
    15.2K sh
    Aug 28, 2006Aug 31, 2026
    traded Aug 28, 2006
    +7308dSEC Form 4

    Evidence

    50
    LB
    Laughton Mary BethDirector
    CARTMaplebear Inc.
    Open-market sale
    SELL$515K
    10.2K sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence

    48
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale
    SELL$18.20M
    600.0K sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence

    46
    AR
    Antz Christoph RudigerDirector, Chief Executive Officer
    VRXAVeraxa Biotech AG - Post de-SPAC
    Open-market purchase
    BUY$7,650
    5,000 sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence

    45
    JF
    Jaros Carey F.Director
    GOGrocery Outlet Holding Corp.
    Open-market purchase
    BUY$176K
    15.0K sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence

    44
    AL
    Agress Adam LEVP Business Development
    KTCCKEY TRONIC CORP
    Open-market sale
    SELL$6,654
    1,784 sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence

    44
    GK
    Gibson Dwight Audley KonradDirector
    AMRZAmrize Ltd
    Open-market purchase
    BUY$244
    5 sh
    Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    +4dSEC Form 4

    Evidence